We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Momenta, Teva Spat Over Copaxone Patents Headed to Trial
Momenta, Teva Spat Over Copaxone Patents Headed to Trial
September 10, 2010
A patent disagreement that could lead to generics of Teva Pharmaceutical’s blockbuster multiple sclerosis (MS) treatment Copaxone is heading for trial now that a federal judge has denied a motion for summary judgment.